Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling
- DOI
- 10.3892/ijo.2017.3943
- Published
- 2017-04-03
- Container
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3892/ijo.2017.3943,
title = {Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling},
author = {Feng Gao and Fa-Gang Wang and Ren-Rong Liu and Feng Xue and Jian Zhang and Guang-Qi Xu and Jian-Hai Bi and Zhen Meng and Ran Huo},
year = {2017},
journal = {International Journal of Oncology},
doi = {10.3892/ijo.2017.3943},
url = {https://doi.org/10.3892/ijo.2017.3943}
}RIS
TY - JOUR TI - Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling AU - Feng Gao AU - Fa-Gang Wang AU - Ren-Rong Liu AU - Feng Xue AU - Jian Zhang AU - Guang-Qi Xu AU - Jian-Hai Bi AU - Zhen Meng AU - Ran Huo PY - 2017 JO - International Journal of Oncology DO - 10.3892/ijo.2017.3943 UR - https://doi.org/10.3892/ijo.2017.3943 ER -
APA
Gao, F., Wang, F., Liu, R., Xue, F., Zhang, J., Xu, G., Bi, J., Meng, Z., & Huo, R. (2017). Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling. International Journal of Oncology. https://doi.org/10.3892/ijo.2017.3943
Source records
- crossref · retrieved 2026-09-25T08:28:38.880Z